Nabsys Launches Tool to Analyze Genetic Repeat Expansions Linked to Inherited Disorders
New software allows researchers to examine repeat expansions associated with up to 23 disease-related genetic regions in a single run.
Category: Company News
Company News
Latest
Company News
Latest
Castle Biosciences Opens 55,000-Square-Foot Scottsdale Laboratory
Castle Biosciences has opened a 55,000-square-foot laboratory in Scottsdale, Arizona, expanding its testing capacity with upgraded infrastructure and operational redundancy, the company announced in a press release.
Company News
Latest
PixCell Medical Expands HemoScreen Hematology Analyzer into Canada
PixCell Medical has received Health Canada Class III licensing for its HemoScreen point-of-care hematology analyzer and signed a Canadian distribution agreement with Inter Medico, expanding access to decentralized CBC testing.
Seed Healthcare Leads Strategic Investment in Diadem for US Commercialization of Alzheimer’s Diagnostic
Seed Healthcare has led a strategic investment in Diadem to support US commercialization of AlzoSure Predict, a blood-based Alzheimer’s diagnostic recently validated in over 900 patients and designated a Breakthrough Device by the FDA.
Read More
Quest Diagnostics to Launch FDA-Cleared Alzheimer Blood Test and Multi-Biomarker Panel
Quest Diagnostics will launch an FDA-cleared Roche pTau217 Alzheimer’s blood test and a new multi-biomarker LDT, expanding its AD-Detect portfolio for improved diagnostic accuracy in late 2026.
Read More
Labcorp to Offer First FDA-Cleared Blood Test for Alzheimer Disease Pathology
Labcorp will offer the FDA-cleared Elecsys pTau-217 blood test, developed by Roche Diagnostics, to aid in identifying amyloid pathology linked to Alzheimer’s in patients 55 and older with cognitive decline.
Read More
Craif Secures $34 Million to Launch Urine-Based Cancer Test in US Market
Craif Inc has raised $34 million in Series D funding to support a US launch of its urine-based cancer test, expand San Diego lab operations, and advance a pancreatic cancer study and regulatory filing in Japan.
Read More
Labcorp, NACHC Alliance Will Use Laboratory Data to Improve Community Health
The strategic alliance will leverage de-identified laboratory data to support quality improvement across 1,526 community health centers and includes a leadership exchange program for chief medical officers.
Read More
AI Platform Will Extract Clinical Insights from Laboratory and Pathology Data for IBD and MASH Research
Century Health and GI Partners of Illinois have partnered to create a real-world data ecosystem for IBD and MASH, leveraging AI to extract clinical insights from lab data, pathology reports, and imaging to support research and pharmaceutical innovation.
Read More
Cerenome Selects XiFin for CNSide Assay Revenue Cycle Management
Cerenome’s CNSide Diagnostics has selected XiFin to provide automated revenue cycle management for its cerebrospinal fluid assay platform, aiming to support increased test volumes and streamline billing as payer coverage expands.
Read More
Epredia to Incorporate Leeds NHS TANGO Technology into Pathology Slides
Epredia will incorporate Leeds NHS Trust’s TANGO quality control technology into pathology slides, aiming to enhance staining consistency for digital pathology and AI diagnostics. Integration is set to begin in late 2026.
Read More
BRAINBox Solutions Secures Funding for Point-of-Care Concussion Testing
BRAINBox Solutions has secured financing from Pivotal Capital Partners and New Horizon Bank to advance its point-of-care and lab-based concussion diagnostic devices for traumatic brain injury.
Read More
VolitionRx Advances Licensing Discussions and Clinical Testing Pillars
VolitionRx reports progress in licensing talks with over 12 diagnostic firms and advances in clinical and veterinary assays, including a reimbursement submission for its Nu.Q Lung Cancer test and a feline lymphoma study milestone.
Read More
Volition Lateral Flow Prototype Correlates with Automated Sepsis Assay
VolitionRx reports its finger-prick lateral flow prototype for sepsis shows strong correlation with its automated Nu.Q NETs assay, supporting point-of-care nucleosome testing for critically ill patients.
Read More
Astorg Completes Acquisition of Thermo Fisher Microbiology Business
Astorg has completed its acquisition of Thermo Fisher’s global microbiology business, establishing an independent diagnostics company. Dirk Bontridder has been named CEO.
Read More
FDA Clears QIAGEN Bloodstream Infection Panel
QIAGEN has received FDA clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, enabling detection of 20 pathogens and 10 antimicrobial resistance markers from positive blood cultures in about one hour.
Read More
bioMérieux Highlights Impact of Rapid Diagnostics and Receives Service Awards at ADLM 2026
bioMérieux hosted a panel on diagnostic delays and received seven 2026 IMV ServiceTrak awards for system performance and customer support at the ADLM Annual Conference & Clinical Lab Expo.
Read More
Cancer Detection Test Receives Regulatory Marking for Use in Great Britain
Personalis has received UKCA marking for its NeXT Personal Dx test, enabling clinical use of its minimal residual disease detection technology across Great Britain, the company announced.
Read More